Radiopharm Theranostics Limited (RADX)

Radiopharm Theranostics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	18.58	18.58	11.7	26.98	0.03
Cash & Short-Term Investments	18.58	18.58	11.7	26.98	0.03
Cash Growth	58.77%	58.77%	-56.64%	99486.97%	-
Accounts Receivable	-	-	0.1	0.06	-
Other Receivables	0.99	0.99	4.36	0	0.01
Receivables	0.99	0.99	4.47	0.06	0.01
Other Current Assets	3.29	3.29	0.13	0.23	-
Total Current Assets	22.85	22.85	16.3	27.26	0.03
Property, Plant & Equipment	0.06	0.06	0.07	0	-
Other Intangible Assets	49.09	49.09	58.54	56.08	-
Other Long-Term Assets	0.04	0.04	0.04	0.04	-
Total Assets	72.04	72.04	74.95	83.38	0.03
Accounts Payable	6.43	6.43	2.96	1.19	0.06
Accrued Expenses	2.57	2.57	2.11	1.02	0.03
Short-Term Debt	-	-	-	-	0.06
Other Current Liabilities	8.57	8.57	8.16	5.66	-
Total Current Liabilities	17.58	17.58	13.23	7.88	0.16
Other Long-Term Liabilities	27.11	27.11	16.14	12.54	-
Total Liabilities	44.68	44.68	29.37	20.42	0.16
Common Stock	100.68	100.68	97.23	86.76	0
Retained Earnings	-111.34	-111.34	-65.35	-30.91	-0.49
Comprehensive Income & Other	38.78	38.78	12.51	7.11	0.36
Total Common Equity	28.12	28.12	44.38	62.96	-0.12
Minority Interest	-0.77	-0.77	1.19	-	-
Shareholders' Equity	27.35	27.35	45.58	62.96	-0.12
Total Liabilities & Equity	72.04	72.04	74.95	83.38	0.03
Total Debt	-	-	-	-	0.06
Net Cash (Debt)	18.58	18.58	11.7	26.98	-0.03
Net Cash Growth	58.77%	58.77%	-56.64%	-	-
Net Cash Per Share	0.05	0.05	0.04	0.15	-
Filing Date Shares Outstanding	2,173	2,173	339.31	255.43	100
Total Common Shares Outstanding	460.37	460.37	339.31	255.43	100
Working Capital	5.27	5.27	3.07	19.39	-0.12
Book Value Per Share	0.06	0.06	0.13	0.25	-0.00
Tangible Book Value	-20.96	-20.96	-14.16	6.89	-0.12
Tangible Book Value Per Share	-0.05	-0.05	-0.04	0.03	-0.00

Source: S&P Capital IQ. Standard template. Financial Sources.